| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/29/2009 | CA2443019C Kappa-opiate agonists for the treatment of bladder diseases |
| 12/29/2009 | CA2424522C Substituted benzene derivatives or salts thereof |
| 12/29/2009 | CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels |
| 12/24/2009 | US20090318517 Novel Compounds 148 |
| 12/24/2009 | US20090318513 Compounds exhibiting thrombopoietin receptor agonism |
| 12/24/2009 | US20090318464 New Pyridine Analogues V |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318383 Compositions and methods for modulation of vascular structure and/or function |
| 12/24/2009 | US20090318365 Metastin derivatives and use thereof |
| 12/24/2009 | US20090318361 Anti-hemorrhage medication pack |
| 12/24/2009 | US20090317488 Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof |
| 12/24/2009 | US20090317454 Body or plant part dressing |
| 12/24/2009 | US20090317385 Methods Using Immunomodulatory Compounds for Modulating Level of CD59 |
| 12/24/2009 | DE10262084B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage |
| 12/23/2009 | WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
| 12/23/2009 | WO2009154237A1 Stabilizer for lymph vessel |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009154190A1 Pyridone compound |
| 12/23/2009 | WO2009153448A1 Oral composition containing an anti-plaque agent of the thienopyridine family in the form of a base |
| 12/23/2009 | WO2009134130A3 Treatment of bleeding with low half-life fibrinogen |
| 12/23/2009 | WO2009120396A3 Compositions and methods for regulating erythropoientin expression and ameliorating anemia and stimulating erythropoiesis |
| 12/23/2009 | WO2009116894A3 Oxygen-transferring blood substitute and a pharmaceutical composition (variants) |
| 12/23/2009 | WO2009063029A3 Substituted amides, manufacturing and use thereof as medicaments |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
| 12/23/2009 | EP2134843A1 Kunitz-type recombinant inhibitor |
| 12/23/2009 | EP1748760B1 Superloaded liposomes for drug delivery |
| 12/23/2009 | EP1534390B1 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene hydrazino -2'-hydroxy- 1,1'-biphenyl -3-carboxylic acid bis-(monoethanolamine) |
| 12/23/2009 | CN101611028A Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 12/23/2009 | CN101611023A 1-phenyl 1-thio-d-glucitol derivative |
| 12/23/2009 | CN101611019A Macrocyclic factor VIIa inhibitors useful as anticoagulants |
| 12/23/2009 | CN101610767A Combination therapy of substituted oxazolidinones |
| 12/23/2009 | CN101608176A Tabanus yao fibrinogen hydrolase tabfiblysin, gene and application thereof |
| 12/23/2009 | CN101607991A Method for preparing venom edema factor inhibition protein and application thereof |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN101607049A Separation and concentration method of drug extract liquid for preparing hemorrhoid diminishing preparation |
| 12/23/2009 | CN101607003A High-efficiency extraction method of effective ingredients in golden camellia tea and application thereof in cigarette preparation |
| 12/23/2009 | CN101606995A Traditional Chinese medicine for treating metrorrhagia |
| 12/23/2009 | CN101606954A Method for extracting and purifying flavonoid substance from selaginella tamariscina |
| 12/23/2009 | CN101606949A Rapid haemostat using mipor starch with high specific surface area as main raw material and preparation process thereof |
| 12/23/2009 | CN101606935A Solid medicinal composition containing clopidogrel |
| 12/23/2009 | CN101606918A Clopidogrel hydrogensulfate enteric-coated sustained-release tablet and preparation thereof |
| 12/23/2009 | CN101606740A Method for preparing sugarless mulberry leaf beverage and application thereof |
| 12/23/2009 | CN101606698A Natural colour viscera-nourishing nutritional noodles and preparation method |
| 12/23/2009 | CN101606692A Natural colour viscera-nourishing nutritional porridge and preparation method |
| 12/23/2009 | CN100572547C Method for extracting and purifying dermatan sulfate in angler fish skin |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/23/2009 | CN100572376C Imidazole derivatives used as TAFIA inhibitors |
| 12/23/2009 | CN100571714C Blood replacing base liquid for blood purification treatment |
| 12/23/2009 | CN100571712C Preparation method for externally used ophicalcitum compound emergency life saving hemostatic |
| 12/23/2009 | CN100571711C Preparing technique of zeolite type quick hemostasis agent |
| 12/23/2009 | CN100571686C Compound drop pills with Chinese medicinal effective part and its preparation method |
| 12/23/2009 | CA2728156A1 Pyridone compounds |
| 12/22/2009 | US7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2473662C Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 12/22/2009 | CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same |
| 12/22/2009 | CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/17/2009 | WO2009152431A1 P2y1 receptor antagonists |
| 12/17/2009 | WO2009151691A2 Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| 12/17/2009 | WO2009151090A1 Rapidly disintegrating preparation containing calcium carbonate |
| 12/17/2009 | WO2009150753A1 Blood coagulation reaction inhibitor |
| 12/17/2009 | WO2009150524A1 Process for preparing a benzoylbenzeneacetamide derivative |
| 12/17/2009 | WO2009150257A2 Compositions for treating rosacea |
| 12/17/2009 | WO2009149851A1 New co-crystal compound of rivaroxaban and malonic acid |
| 12/17/2009 | WO2009149795A2 Heterocyclic cyclopropyl-substituted fxr binding compounds |
| 12/17/2009 | WO2009126822A9 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation |
| 12/17/2009 | WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors |
| 12/17/2009 | US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | US20090312368 Pyridine Analogues IV |
| 12/17/2009 | US20090311344 Dosing Regimen |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | DE10315030B4 Zyklische Peptide, Verfahren zu deren Herstellung und deren medizinische Verwendung Cyclic peptides, process for their preparation and to their medical use |
| 12/17/2009 | CA2731138A1 Compositions for treating rosacea |
| 12/17/2009 | CA2717045A1 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 12/17/2009 | CA2716860A1 Compounds and method for reducing uric acid |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133098A1 G-CSF conjugates |
| 12/16/2009 | EP2132220A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 12/16/2009 | EP2132193A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications |
| 12/16/2009 | EP1888567B1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1147176B1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 12/16/2009 | CN101605779A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 12/16/2009 | CN101602801A Polyethyleneglycol modificatory tecombined human granulocyte colony stimulating factor mutant |
| 12/16/2009 | CN101602768A Method for purifying sesamin and sesamolin |
| 12/16/2009 | CN101602765A 6-alkyl amino-2-alkylthio-9-ester-containing alkylpurine derivatives and method for synthesizing same |
| 12/16/2009 | CN101602735A Preparation method of ligustrazine |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601859A Application of nattokinase in preparing cerebral protective agent type drugs |
| 12/16/2009 | CN101601850A Lactagogue and health care traditional Chinese medicine for lying-in women |
| 12/16/2009 | CN101601835A Tumor post-operation treating medicine and preparation method thereof |
| 12/16/2009 | CN101601834A Preparation method of soup for eliminating edema |
| 12/16/2009 | CN101601815A Medicament for hemostasis |
| 12/16/2009 | CN101601808A Preparation method of oral wine for soothing nerves, tonifying yang and enriching blood |